Quick Answer
ADIAL PHARMACEUTICALS, INC. reported Stockholders Equity of $5.28 million for fiscal year 2025.
ADIAL PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $5.28M | +29.7% |
| 2024 | $4.07M | -0.4% |
| 2023 | $4.08M | +24.6% |
| 2022 | $3.28M | -6.6% |
| 2021 | $3.51M | -12.0% |
| 2020 | $3.99M | -44.2% |
| 2019 | $7.14M | +60.8% |
| 2018 | $4.44M | +545.2% |
| 2017 | -$997.6K | -863.9% |
| 2016 | -$103.5K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.51M | -23.4% | -19.4% |
| June 30, 2025 | $5.59M | +30.7% | +162.9% |
| March 31, 2025 | $2.13M | -65.3% | -47.7% |
| December 31, 2024 | $4.07M | -0.4% | -30.9% |
| September 30, 2024 | $5.88M | +151.5% | +37.6% |
| June 30, 2024 | $4.28M | +28.9% | -30.1% |
| March 31, 2024 | $6.12M | +325.2% | +49.9% |
| December 31, 2023 | $4.08M | +24.6% | +74.6% |
- ADIAL PHARMACEUTICALS, INC. showed an increase of +29.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2025 period, ADIAL PHARMACEUTICALS, INC.’s stockholders equity has grown by 5198.4% (from -$103.5 thousand to $5.28 million).
- The most recent figure is from ADIAL PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: